Tower Research Capital (TRC)’s Everus Construction Group ECG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Buy
2,001
+1,300
+185% +$135K 0.01% 1490
2025
Q4
$60K Sell
701
-1,096
-61% -$98.1K ﹤0.01% 2292
2025
Q3
$154K Buy
1,797
+635
+55% +$47.2K ﹤0.01% 1675
2025
Q2
$73.8K Buy
1,162
+768
+195% +$38.9K ﹤0.01% 2635
2025
Q1
$14.6K Sell
394
-5,854
-94% -$315K ﹤0.01% 3279
2024
Q4
$411K Buy
+6,248
New +$393K 0.01% 1207

Other funds holding ECG

Tower Research Capital (TRC)'s ECG Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Everus Construction Group (ECG) stake by 185% in Q1 2026, buying an estimated $135K and bringing the position to 2,001 shares worth $236K. The position accounts for 0.01% of the portfolio, ranked #1490.

Tower Research Capital (TRC) first reported a position in ECG in Q4 2024 and has held it in 6 quarters since. The position peaked at $411K in Q4 2024. 489 funds tracked by Wall St. Rank hold ECG as of Q1 2026.

  • Tower Research Capital (TRC) held 2,001 shares of Everus Construction Group worth $236K as of Q1 2026.
  • Tower Research Capital (TRC) bought 1,300 Everus Construction Group shares in Q1 2026, an estimated $135K.
  • Everus Construction Group made up 0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1490 holding.
  • Tower Research Capital (TRC) first reported a position in Everus Construction Group in Q4 2024 and has held it in 6 quarters since.
  • Tower Research Capital (TRC)'s Everus Construction Group position peaked at $411K in Q4 2024.
  • 489 funds tracked by Wall St. Rank held Everus Construction Group as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.